| Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ... Jama 321 (1), 69-79, 2019 | 1098 | 2019 |
| Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA DK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ... Circulation 139 (3), 351-361, 2019 | 165 | 2019 |
| Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction S Liu, K Li, L Wagner Florencio, L Tang, TR Heallen, JP Leach, Y Wang, ... Science translational medicine 13 (600), eabd6892, 2021 | 91 | 2021 |
| Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a … J Rosenstock, V Perkovic, JH Alexander, ME Cooper, N Marx, MJ Pencina, ... Cardiovascular diabetology 17, 1-15, 2018 | 89 | 2018 |
| Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial GJ Biessels, C Verhagen, J Janssen, E van den Berg, B Zinman, ... Diabetes care 42 (10), 1930-1938, 2019 | 68 | 2019 |
| Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: secondary analysis of the CARMELINA randomized trial V Perkovic, R Toto, ME Cooper, JFE Mann, J Rosenstock, DK McGuire, ... Diabetes care 43 (8), 1803-1812, 2020 | 58 | 2020 |
| Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified … ME Cooper, J Rosenstock, T Kadowaki, Y Seino, C Wanner, S Schnaidt, ... Diabetes, Obesity and Metabolism 22 (7), 1062-1073, 2020 | 17 | 2020 |
| Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial C Wanner, ME Cooper, OE Johansen, R Toto, J Rosenstock, DK McGuire, ... Clinical kidney journal 14 (1), 226-236, 2021 | 10 | 2021 |
| A robust percutaneous myocardial infarction model in pigs and its effect on left ventricular function K Li, L Wagner, A Moctezuma-Ramirez, D Vela, E Perin Journal of cardiovascular translational research, 1-10, 2021 | 6 | 2021 |
| Functional Recovery After Gene Therapy and Hippo Pathway Knock Down After Myocardial Infarction in a Pig Model S Liu, K Li, T Heallen, L Tang, Y Wang, L Wagner, JT Willerson, EC Perin, ... Circulation Research 127 (Suppl_1), A293-A293, 2020 | | 2020 |
| INJECTION INDUCED MYOCARDIAL STUNNING: ACUTE DETERIORATION OF LEFT VENTRICULAR EJECTION FRACTION FOLLOWING TRANSENDOCARDIAL INJECTIONS LWF Dos Santos, K Li, S Kuchibhotla, E Perin Journal of the American College of Cardiology 73 (9S1), 1011-1011, 2019 | | 2019 |
